(Q43698345)

26 November 2017

Functional neuroanatomy of the ventral striopallidal GABA pathway. New sites of intervention in the treatment of schizophrenia (English)

1 reference

26 November 2017

1 reference

1

1 reference

26 November 2017

1 August 2001

1 reference

26 November 2017

9

1 reference

Journal of Neuroscience Methods

inferred from page(s)

published in

1 reference

26 November 2017

109

1 reference

26 November 2017

1

1 reference

26 November 2017

31-39

1 reference

The concentrations of free amino acids and other electrolytes in cerebrospinal fluid, in vivo dialysate of brain, and blood plasma of the dog

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

Amphetamine lowers extracellular GABA concentration in the ventral pallidum.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

Modulation of Extracellular γ‐Aminobutyric Acid in the Ventral Pallidum Using In Vivo Microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

Two faces of cholecystokinin: anxiety and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

Neurotransmitter interactions in schizophrenia--therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

Inactivation of neurotensin by rat brain synaptic membranes partly occurs through cleavage at the Arg8-Arg9 peptide bond by a metalloendopeptidase

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

Cholecystokinin-dopamine interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

Evidence that decreased feeding induced by systemic injection of cholecystokinin is mediated by CCK-A receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

Characterization of gamma-aminobutyric acid and dopamine overflow following acute implantation of a microdialysis probe

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

Regional specific effects of clozapine and haloperidol on GABA and dopamine release in rat basal ganglia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

Peptidase inhibitors potentiate the effects of neurotensin and neuromedin N on self-stimulation of the medial prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

Evidence for a differential cholecystokinin-B and -A receptor regulation of GABA release in the rat nucleus accumbens mediated via dopaminergic and cholinergic mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

Differential effects of intrastriatal neurotensin(1-13) and neurotensin(8-13) on striatal dopamine and pallidal GABA release. A dual-probe microdialysis study in the awake rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

Evidence for a nucleus accumbens CCK2 receptor regulation of rat ventral pallidal GABA levels: a dual probe microdialysis study.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

Antagonistic interaction between adenosine A2A receptors and dopamine D2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

Adenosine-dopamine interactions in the ventral striatum. Implications for the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

Intramembrane interactions between neurotensin receptors and dopamine D2 receptors as a major mechanism for the neuroleptic-like action of neurotensin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

Evidence for a substrate of neuronal plasticity based on pre- and postsynaptic neurotensin-dopamine receptor interactions in the neostriatum

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

Striatal interneurones: chemical, physiological and morphological characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

The role of the striatopallidal and extended amygdala systems in drug addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

Cholecystokinin (CCK) increases GABA release in the rat anterior nucleus accumbens via CCK(B) receptors located on glutamatergic interneurons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

Amphetamine regulation of acetylcholine and gamma-aminobutyric acid in nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

Dopamine D1 and D2 receptor antagonism differentially modulates stimulation of striatal neurotransmitter levels by N-methyl-D-aspartic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

CCK-B receptor: chemistry, molecular biology, biochemistry and pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

An in vivo microdialysis characterization of extracellular dopamine and GABA in dorsolateral striatum of awake freely moving and halothane anaesthetised rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

The effects of neurotensin on GABA and acetylcholine release in the dorsal striatum of the rat: an in vivo microdialysis study.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

Differential cholinergic regulation of dopamine release in the dorsal and ventral neostriatum of the rat: an in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

Functional neuroanatomy of the basal ganglia as studied by dual-probe microdialysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

Acute versus chronic haloperidol: relationship between tolerance to catalepsy and striatal and accumbens dopamine, GABA and acetylcholine release.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

Comparative localization of neurotensin receptors on nigrostriatal and mesolimbic dopaminergic terminals

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

The effects of intranigral GABA and dynorphin A injections on striatal dopamine and GABA release: evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

CSF neurotensin concentrations and antipsychotic treatment in schizophrenia and schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

Facilitation of GABA release by neurotensin is associated with a reduction of dopamine release in rat nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

Phosphorus‐containing peptides as mixed inhibitors of endopeptidase 3.4.24.15 and 3.4.24.16: effect on neurotensin degradation in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis--II. Effects of dopamine D1 and D2 receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900398-3

7 January 2021

10.1016/S0165-0270(01)00398-3

Identifiers

DOI

1 reference

26 November 2017

1 reference

PubMed ID

11489297